Sign in
Huntington's disease therapeutic compounds
Patent   Open access

Huntington's disease therapeutic compounds

Beverly L Davidson and Alejandro Mas Monteys
United States Patent and Trademark Office
12/20/2016
pdf
Huntingtons disease therapeutic compounds687.19 kBDownloadView
PDM V1.0 Open Access

Abstract

The present invention is directed to RNA interference (RNAi) molecules targeted against a Huntington's disease nucleic acid sequence, and methods of using these RNAi molecules to treat Huntington's disease.

Details

Metrics

40 File views/ downloads
41 Record Views